In March, Levofloxacin Hemihydrate in the US market firmed as import-parity offers strengthened and restocking progressed. Indian exporters raised export quotations while GMP operating rates were maintained, reducing exportable surplus. Hospital tenders prompted distributors to rebuild safety stock after winter drawdowns. Freight surcharges on the Asia–U.S. West Coast and batch validations constrained spot availability, with Los Angeles bonded inventory at the lower end of ranges. The result was an upward bias driven by healthcare restocking and tighter Indian export flows. Demand remained strongest in the healthcare channel, with hospitals and group-purchasing organizations securing tenders for anti-infectives and finished-dose products; retail pharmacy contributed steady pull-through for Tier-6 antibiotics. Conversely, Indian API producers pulled additional volumes for internal use, further tightening exportable supply. Logistics costs supported the delivered premium; Indian export dependence remained high, with domestic sourcing limited. Near-term momentum is expected to endure, with forecasts for gains before a modest pause later in the year, subject to feedstock and policy dynamics.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
